Mucus hypersecretion with elevated MUC5B mucin production is a pathologic feature in many airway diseases associated with oxidative stress. In the present work, we evaluated MUC5B expression in airways and in primary cultures of normal human bronchial epithelial (NHBE) cells, as well as the mechanisms involved in its regulation. We found that oxidative stress generated by cigarette smoke or reactive oxygen species (ROS) induces MUC5B up-regulation in airway epithelium from smokers and in NHBE cells, respectively. We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on hyaluronan depolymerization and epidermal growth factor receptor (EGFR)/mitogenactivated protein kinase (MAPK) activation. Since hyaluronan fragments can activate MAPK through the hyaluronan receptor CD44, and CD44 heterodimerizes with EGFR, we tested whether ROS and/ or hyaluronan fragments induce MUC5B mRNA and protein expression through CD44/EGFR. We found that ROS promotes CD44/EGFR interaction, EGFR/MAPK activation, and MUC5B up-regulation that are prevented by blocking CD44 and/or EGFR. These results were mimicked by hyaluronan fragments. In summary, our results show that oxidative stress in vivo (cigarette smoke) or in vitro (ROS) induces MUC5B up-regulation. This ROS-induced MUC5B expression requires CD44 as well as EGFR and MAPK activation. In addition, we also provide evidence that hyaluronan fragments are sufficient to induce CD44/EGFR interaction and downstream signaling that results in MUC5B up-regulation, suggesting that hyaluronan depolymerization during inflammatory responses could be directly involved in the induction of mucus hypersecretion.Keywords: MUC5B; hyaluronan fragments; CD44; airway epithelium Mucus overproduction occurs in a variety of acute reactions to cigarette smoke (1) and microorganisms (2, 3), as well as in chronic airway inflammatory diseases such as chronic bronchitis (4-6), asthma (7-9), bronchiectasis (10), and cystic fibrosis (11). The major macromolecular components of mucus are large and heavily glycosylated mucin proteins that are encoded by various MUC genes (12)(13)(14), that maintain airways homeostasis by protecting the epithelial surface from environmental insults. MUC5B and MUC5AC are the major mucins present in airways secretions from patients with asthma (15-17), cystic fibrosis (18,19), and chronic obstructive pulmonary disease (COPD) (1). In normal airways, MUC5AC and MUC5B are typically described as produced by goblet cells at the surface epithelium (20) and by mucous cells in submucosal glands (21), respectively. However, MUC5B mucin is also present at low levels in airway epithelium from normal lung donors (22) and up-regulated in patients with airways diseases and inflammation (1,(23)(24)(25)(26)(27). Nevertheless, it is not clear whether MUC5B and MUC5AC are produced by the same or by different cell populations in airway epithelium, since co-localization studies have not been done. Compared with MUC5AC expression regulation, the pathways involved in the regu...